479 related articles for article (PubMed ID: 16278384)
1. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas.
Feltmate CM; Lee KR; Johnson M; Schorge JO; Wong KK; Hao K; Welch WR; Bell DA; Berkowitz RS; Mok SC
Clin Cancer Res; 2005 Nov; 11(21):7651-7. PubMed ID: 16278384
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.
Szych C; Staebler A; Connolly DC; Wu R; Cho KR; Ronnett BM
Am J Pathol; 1999 Jun; 154(6):1849-55. PubMed ID: 10362811
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of synchronous mucinous tumors of the ovary and appendix.
Chuaqui RF; Zhuang Z; Emmert-Buck MR; Bryant BR; Nogales F; Tavassoli FA; Merino MJ
Hum Pathol; 1996 Feb; 27(2):165-71. PubMed ID: 8617458
[TBL] [Abstract][Full Text] [Related]
4. Synchronous serrated adenoma of the appendix and high-grade ovarian carcinoma: a case demonstrating different origin of the two neoplasms.
Rudzki Z; Zazula M; Białas M; Klimek M; Stachura J
Pol J Pathol; 2002; 53(1):29-34. PubMed ID: 12014223
[TBL] [Abstract][Full Text] [Related]
5. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
6. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
[TBL] [Abstract][Full Text] [Related]
7. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
8. Analysis of loss of heterozygosity for tumor-suppressor genes can accurately classify and predict the clinical behavior of mucinous tumors arising from the appendix.
Maheshwari V; Tsung A; Lin Y; Zeh HJ; Finkelstein SD; Bartlett DL
Ann Surg Oncol; 2006 Dec; 13(12):1610-6. PubMed ID: 17009159
[TBL] [Abstract][Full Text] [Related]
9. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
10. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
11. Mucinous and nonmucinous appendiceal adenocarcinomas: different clinicopathological features but similar genetic alterations.
Kabbani W; Houlihan PS; Luthra R; Hamilton SR; Rashid A
Mod Pathol; 2002 Jun; 15(6):599-605. PubMed ID: 12065772
[TBL] [Abstract][Full Text] [Related]
12. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
[TBL] [Abstract][Full Text] [Related]
14. Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors.
Wang VW; Bell DA; Berkowitz RS; Mok SC
Cancer Res; 2001 May; 61(10):4169-74. PubMed ID: 11358841
[TBL] [Abstract][Full Text] [Related]
15. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
[TBL] [Abstract][Full Text] [Related]
17. Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix.
Guerrieri C; Frånlund B; Boeryd B
Mod Pathol; 1995 Jun; 8(5):573-6. PubMed ID: 7545815
[TBL] [Abstract][Full Text] [Related]
18. Loss of SMAD4 protein expression is associated with high tumor grade and poor prognosis in disseminated appendiceal mucinous neoplasms.
Davison JM; Hartman DA; Singhi AD; Choudry HA; Ahrendt SA; Zureikat AH; Ramalingam L; Nikiforova M; Pai RK
Am J Surg Pathol; 2014 May; 38(5):583-92. PubMed ID: 24618609
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
20. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
